Applications of Functional Genomics for Drug Discovery

SLAS Discov. 2020 Sep;25(8):823-842. doi: 10.1177/2472555220902092. Epub 2020 Feb 6.

Abstract

Many diseases, such as diabetes, autoimmune diseases, cancer, and neurological disorders, are caused by a dysregulation of a complex interplay of genes. Genome-wide association studies have identified thousands of disease-linked polymorphisms in the human population. However, detailing the causative gene expression or functional changes underlying those associations has been elusive in many cases. Functional genomics is an emerging field of research that aims to deconvolute the link between genotype and phenotype by making use of large -omic data sets and next-generation gene and epigenome editing tools to perturb genes of interest. Here we review how functional genomic tools can be used to better understand the biological interplay between genes, improve disease modeling, and identify novel drug targets. Incorporation of functional genomic capabilities into conventional drug development pipelines is predicted to expedite the development of first-in-class therapeutics.

Keywords: CRISPR; RNAi; cell-based assays; epigenetics; gene editing; genomics; shRNA.

Publication types

  • Review

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Drug Discovery / trends*
  • Epigenome / genetics
  • Gene Editing
  • Genetic Predisposition to Disease*
  • Genome, Human / genetics*
  • Genome-Wide Association Study
  • Genomics / trends*
  • Genotype
  • Humans
  • Phenotype
  • RNA, Small Interfering / genetics

Substances

  • RNA, Small Interfering